Open AccessHyponatraemia induced by low-dose intravenous pulse cyclophosphamide
Author(s) -
Yong Chan Lee,
JinSeok Park,
ChangHun Lee,
SangCheol Bae,
I. S. Kim,
Chong Myung Kang,
GheunHo Kim
Publication year - 2009
Publication title -
nephrology dialysis transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.654
H-Index - 168
eISSN - 1460-2385
pISSN - 0931-0509
DOI - 10.1093/ndt/gfp657
Subject(s) - cyclophosphamide , medicine , gastroenterology , chemotherapy , urology
Cyclophosphamide is an alkylating agent and was traditionally known to potentiate the renal action of vasopressin. Although low-dose intravenous pulse cyclophosphamide therapy is being used extensively in the treatment of malignant and rheumatological diseases, there have been only a few case reports of cyclophosphamide-induced hyponatraemia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom